When to Reassess Protocol Signs of Positive Response Improved energy consistency and reduced afternoon fatigue (week 1-4) Faster healing of minor cuts and skin blemishes (week 2-4) Visible skin tone evening reduced dullness, brighter complexion (week 4-8) Declining AST/ALT on bloodwork (week 4-8) Reduced hs-CRP indicating lower systemic inflammation (week 4-8) Nail quality improvements reduced brittleness, improved growth (week 4-8) Signs to Reassess No subjective or objective changes after 8 weeks evaluate delivery route first
When administered intravenously, Glutathione IV therapy offers several potential benefits: Anti-Oxidation: Glutathione is a powerful antioxidant that neutralizes harmful free radicals in our body
Vitamin B12 Deficiency and the Nervous System: Beyond Metabolic DecompensationComparing Biological Models and Gaining New Insights into Molecular and Cellular Mechanisms
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
Annual Review of Pharmacology and Toxicology, 49 , 95-121.
As of mid-2026, neither compound is approved by the FDA or the EMA for any indication , so no established or approved human dose exists for either, and anything sold under those names outside a monitored trial is a research-use-only chemical of unverified identity